Skip to main content

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
  • EDITORIAL BOARD
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
  • SUBSCRIBE

User menu

  • Log in
  • My Cart

Search

  • Advanced search
Journal of Neuroscience
  • Log in
  • My Cart
Journal of Neuroscience

Advanced Search

Submit a Manuscript
  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
  • EDITORIAL BOARD
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
  • SUBSCRIBE
PreviousNext
Articles, Neurobiology of Disease

Human Auditory Cortex Neurochemistry Reflects the Presence and Severity of Tinnitus

William Sedley, Jehill Parikh, Richard A.E. Edden, Valerie Tait, Andrew Blamire and Timothy D. Griffiths
Journal of Neuroscience 4 November 2015, 35 (44) 14822-14828; DOI: https://doi.org/10.1523/JNEUROSCI.2695-15.2015
William Sedley
1Institute of Neuroscience and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jehill Parikh
2Newcastle Magnetic Resonance Centre, Newcastle University, Newcastle Upon Tyne, NE1 7RU, United Kingdom,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard A.E. Edden
3Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205,
4F.M. Kirby Centre for Functional MRI, Kennedy Krieger Institute, Baltimore, Maryland 21205, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Valerie Tait
5Department of Audiology, Freeman Hospital, Newcastle Upon Tyne, NE7 7DN, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew Blamire
2Newcastle Magnetic Resonance Centre, Newcastle University, Newcastle Upon Tyne, NE1 7RU, United Kingdom,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Andrew Blamire
Timothy D. Griffiths
1Institute of Neuroscience and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

It is not known why tinnitus occurs in some cases of hearing damage but not others. Abnormalities of excitation–inhibition balance could influence whether tinnitus develops and its severity if it does. Animal models of hearing damage, which also produce tinnitus based on behavioral evidence, have identified abnormalities of GABAergic inhibition, both cortically and subcortically. However, the precise relationships of GABA inhibitory changes to tinnitus itself, as opposed to other consequences of hearing damage, remain uncertain. Here, we used magnetic resonance spectroscopy to non-invasively quantify GABA in the left (LAC) and right (RAC) auditory cortices of a group of 14 patients with lateralized tinnitus (eight left ear) and 14 controls matched for age, sex, and hearing. We also explored the potential relationships with other brain metabolites (i.e., choline, N-acetylaspartate, and creatine). The presence of tinnitus was associated with a reduction in auditory cortex GABA concentration. Regardless of tinnitus laterality, post hoc testing indicated reductions that were significant in RAC and nonsignificant in LAC. Tinnitus severity and hearing loss were correlated positively with RAC choline but not GABA. We discuss the results in the context of current models of tinnitus and methodological constraints.

SIGNIFICANCE STATEMENT Permanently affecting one in seven adults, tinnitus lacks both widely effective treatments and adequate understanding of its brain mechanisms. Existing animal models represent tinnitus that may not be distinguishable from homeostatic responses to the auditory insults used to induce it. Human studies can be well controlled in this regard but are usually not (with few even matching control subjects for hearing loss) and are limited in scope as a result of relying solely on non-invasive recording techniques. Here, we exploit recent advances in non-invasive spectroscopic techniques to establish, in a human study tightly controlled for hearing loss and hyperacusis, that tinnitus is associated with a significant reduction in auditory cortex GABA concentration, which has implications for understanding and treatment of the condition.

  • auditory cortex
  • choline
  • GABA
  • MR spectroscopy
  • tinnitus

Introduction

Persistent sensation of sound in one or both ears (tinnitus) commonly results from certain cases of peripheral auditory damage. Although initiated in the periphery, the importance of central mechanisms in tinnitus is highlighted by reduced spontaneous and sound-driven cochlear nerve firing, instances of exacerbation attributable to sectioning the cochlear nerve, and excessive activity in the central auditory pathway (Noreña and Farley, 2013). Although neuronal firing rates are usually elevated in noise trauma animal models, the time course and tonotopic distribution of these may or may not match those of the tinnitus behavior (Eggermont, 2013). However, increased synchrony between neurons has been observed, in certain studies, to begin immediately after noise trauma (thus mirroring tinnitus onset; Noreña and Eggermont, 2003) and in the tonotopic region of noise trauma (Seki and Eggermont, 2003). Human tinnitus patients exhibit excessive neural synchrony, in the form of abnormal spontaneous electromagnetic field/potential oscillations in auditory cortex (Weisz et al., 2007; Adjamian et al., 2012; Tass et al., 2012) and increased responses to sound at various levels of the central auditory pathway (Lanting et al., 2008; Melcher et al., 2009; Gu et al., 2010). Although the exact role of these different types of activity in tinnitus pathogenesis is still debated (Sedley and Cummingham, 2013; De Ridder et al., 2015), they appear important and might plausibly be produced or enhanced by deficient inhibition in the central auditory pathway. If identified, reversing such inhibitory deficiency via pharmacological or other interventions could prove effective in treating tinnitus.

GABA systems in tinnitus

The inhibitory neurotransmitter GABA is instrumental in maintaining excitation–inhibition balances. From first principles, insufficient GABAergic inhibition could underlie tinnitus, or elevated inhibition could act to compensate for it. Changes could take the form of altered gross concentration, relative distribution in the tissue, receptor affinity, or receptor density. The only relevant study measuring GABA directly compared measurements from rats with behavioral evidence of chronic tinnitus, after noise exposure, with those from unexposed controls (Brozoski et al., 2012). Significant differences were found only at the level of the auditory thalamus, contralateral to the exposed ear, with exposed rats showing lower GABA concentrations. Studies using flavoprotein autofluorescence to measure the spatial spread of neural responses have found evidence of reduced GABAergic inhibition, associated with noise trauma animal tinnitus models, in the dorsal cochlear nucleus (Middleton et al., 2011) and auditory cortex (Llano et al., 2012). Chronic salicylate exposure (which causes tinnitus) has been found to result in reduced expression of glutamic acid decarboxylase (which converts glutamate to GABA) and reduced GABA receptor affinity in the inferior colliculus of rats (Bauer et al., 2000). Although indicative of GABAergic deficiency, these studies do not uniquely attribute observed abnormalities to tinnitus specifically, as opposed to other consequences of the auditory insults applied. Indirect evidence of the importance of GABA systems in tinnitus comes from a number of human and animal studies finding improvements in tinnitus measures after administration of drugs that increase GABA concentration (Brozoski et al., 2007) or have a GABAergic action (Han et al., 2012; Zheng et al., 2012). Furthermore, withdrawal from chronic benzodiazepine use is a potent inducer of tinnitus (Busto et al., 1986, 1988), suggesting a direct relationship between GABA systems and tinnitus.

Magnetic resonance spectroscopy in tinnitus patients

Magnetic resonance spectroscopy (MRS) is a non-invasive method capable of making brain neurochemical measurements in humans and has been proposed as a potentially useful tool for studying tinnitus (Cacace and Silver, 2007). We are aware of only one published report of MRS in tinnitus (Kilicarslan et al., 2014), which measured N-acetylaspartate (NAA) and creatine in acoustic neuroma patients but without studying other metabolites or a control group. Therefore, we applied the technique to the bilateral auditory cortices of a group of chronic tinnitus patients and age/hearing-matched controls to highlight abnormalities specifically linked to tinnitus. Given the pre hoc focus on GABA, we used methods optimized for GABA estimation.

Materials and Methods

Subjects.

We studied a group of 14 patients (six females) with predominantly or entirely unilateral tinnitus (eight left, six right) and 14 controls (seven females) matched for age and hearing loss. Lateralized tinnitus was studied to assess hemispheric bias of any neurochemical changes in terms of left versus right and ipsilateral versus contralateral. Exactly half of each group had normal (<20 dB hearing loss) mean hearing thresholds in frequencies between 0.25 and 8 kHz so that the effects of hearing loss on cortical neurochemistry could be studied. Exclusion criteria included any neurological disorder other than tinnitus, the use of sedating or GABA acting medications, and contraindications to MRI.

Assessment of tinnitus phenomenology.

The diagnosis of tinnitus was made based on a clinical history of persistent simple auditory percepts heard all or most of the time, when not being masked by environmental sounds, for a duration of >6 months. Controls were screened for the presence of tinnitus and excluded if they experienced any persistent sounds in either ear on a regular or permanent basis. Quantification of tinnitus severity was performed in three ways: (1) completion of the tinnitus handicap inventory (THI; Newman et al., 1996), which measures the effect of tinnitus rather than its loudness; (2) visual analog scoring (VAS) of subjective tinnitus loudness; and (3) VAS assessment of the distress caused by tinnitus. VAS measures were indicated on a continuous scale from 0 to 10, with 0 being no sound at all or no distress, and 10 being the loudest sound in existence or the most distress it is possible to experience. In a novel approach to disentangling chronic from acute influences on tinnitus (which might have different correlates), for each VAS, subjects provided four responses: (1) an “average” measure, indicating their response with respect to a typical or average day; (2) a “minimum” response, indicating their lowest score applicable over the past 3 months; (3) a “maximum” response, indicating their highest score applicable over the past 3 months; and (4) a “now” measure, indicating their response applicable at the time of the experiment. These measures were converted to two values to be used for the analysis of MRS data: (1) an “overall” score, which was simply the average response; and (2) a “current” score, derived from interpolation, onto a scale of 0–10, of the now score between the minimum and maximum responses, such that the minimum response was 0, the average response was 5, and the maximum response was 10. Hyperacusis was quantified in all subjects using the hyperacusis questionnaire (HQ; Khalfa et al., 2002). Audiological assessment for all subjects included pure tone audiometry (PTA) in 1 dB steps at frequencies of 0.25, 0.5, 1, 2, 4, 6, and 8 kHz. PTA was performed in ascending frequencies in the left and then the right ear, with three repetitions of each frequency in immediate succession, and the median value across the three repetitions was taken.

MRS acquisition.

GABA has three distinct peaks in its magnetic resonance spectrum, but each of these coincides in frequency with the peak of a more abundant metabolite, necessitating the use of a specific GABA measurement technique to quantify its concentration (Puts and Edden, 2012; Mullins et al., 2014). We used the Mescher-Garwood proton resolved spectroscopy (MEGA-PRESS) technique (Mescher et al., 1998), in which alternate acquisitions are applied an editing pulse at 1.9 ppm, which modulates all three of the GABA peaks attributable to J coupling. Subtraction of the EDIT-OFF from EDIT-ON spectra thus allows separation of the GABA signal at 3 ppm from the overlying creatine signal. MEGA-PRESS spectra were acquired from each of the left (LAC) and right (RAC) auditory cortex of each subject on a Phillips Achieva 3 Tesla MRI scanner using an eight-channel head coil. Specific sequence parameters included the following: TR, 2000 ms; TE, 68 ms; 320 averages; acquisition bandwidth, 1000 Hz; scan duration, 11 min; sinc Gaussian editing pulse applied at 1.9 ppm (during EDIT-ON scans) and 7.5 ppm (during EDIT-OFF scans); voxel size, 45 (anteroposterior) × 32 (right to left) × 20 (foot to head) mm for both LAC and RAC; variable power radiofrequency pulses with optimized relaxation delays (VAPOR) water suppression (Tkác et al., 1999). Non-water-suppressed spectra were also obtained from each auditory cortex (PRESS: TE, 68 ms; TR, 2000 ms; 10 averages). Previous T1w structural scans (3D MPRAGE; sagittal acquisition aligned with the anterior commissure–posterior commissure line; 1 mm isotropic resolution; matrix, 240 × 240 × 180; TR, 9.6 ms; TE, 4.6 ms; flip angle, 8°; sensitivity-encoded factor 2) were acquired to aid positioning of the MRS voxels in the LAC and RAC (for details, see Fig. 1). Macromolecular suppression editing was not performed to maximize the signal-to-noise ratio for GABA+ (i.e., GABA plus macromolecules) quantification using the MEGA-PRESS acquisition (Edden et al., 2012). To reduce sources of noise or bias, all subjects were requested to refrain from alcohol for 24 h before the study and caffeine on the day of the study, scans were performed at approximately the same time each morning, the scanner was not used after any high-demand sequences to prevent scanner frequency drifts that might have influenced the MEGA-PRESS acquisition (Harris et al., 2014), and LAC and RAC were scanned in random order. Subjects all listened to music or radio during the acquisition of the structural T1 image and voxel placement and had no acoustic input besides scanner noise during MRS acquisition.

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Example GABA spectrum acquisition from the RAC in one typical subject. A, Orthogonal section view (neurological convention; L, left; R, right) of voxel placement. Voxels were placed parallel with and superiorly abutting the Sylvian fissure and were otherwise centered on Heschl's sulcus. This volume encompassed nearly all of Heschl's gyrus, including the primary auditory cortex, the planum temporale, the superior temporal sulcus, planum polare, and also small parts of the insula and middle temporal gyrus adjacent to these auditory regions. B, Edited spectrum, including the GABA peak for quantification at 3 ppm. C, Expanded view of B, showing 3 ppm GABA peak and fitted Gaussian function used for quantification.

Spectroscopy data analysis. GABA quantification was performed using the Gannet toolbox for MATLAB (Edden et al., 2014) and comprised the following steps: (1) alignment of each pair (EDIT-ON and EDIT-OFF) of spectra (Near et al., 2014); (2) subtraction of edited spectra, to yield GABA spectra, and averaging across acquisitions; and (3) fitting a Gaussian function to the GABA peak at 3 ppm and quantifying GABA based on the area under the curve. For one typical edited spectrum and Gaussian fit, see Figure 1, B and C, respectively. Water level was obtained from a Gaussian–Lorentzian fit to the non-water-suppressed data. Tissue fractions of gray matter (GM), white matter (WM), and CSF within the MRS voxels were calculated based on automated segmentation in SPM12 (http://www.fil.ion.ucl.ac.uk/spm/software/spm12/), using a volume mask generated from the voxel position in Gannet (Harris et al., 2015). The final measurement of interest, GABA concentration, was estimated relative to water amplitude, accounting for metabolite relaxation times and tissue fractions, as discussed by Gao et al. (2015). Choline, creatine, and NAA amplitudes were quantified from non-edited spectra only using the AMARES (Advanced Method for Accurate, Robust, and Efficient Spectral fitting of MRS data with use of prior knowledge) algorithm from jMRUI (Naressi et al., 2001), and similarly to GABA were converted to tissue concentrations by taking account of water level, tissue fractions, and known tissue metabolite relaxation times from the literature (Mlynárik et al., 2001; Ethofer et al., 2003). As part of the quality assurance routine, MRS fit quality was assessed by an experienced physicist; the spectra were rejected if the Gannet fit error was >10% (GABA measurements) or metabolite line width was >12 Hz (NAA, creatine, and choline).

Statistical analysis.

Nonparametric statistics were used, namely the Friedman's test for main effects of group, with Wilcoxon's rank-sum test for post hoc group differences in individual hemispheres, and Spearman's rank correlation coefficients for correlations with tinnitus-related or other continuous variables. GABA was treated as the primary outcome measure and therefore was not subject to multiple comparison correction. Choline, creatine, and NAA were treated as exploratory and therefore subject to Bonferroni's correction. All statistical tests were two tailed.

Results

Spectroscopy results overview

Gaussian fit errors of the GABA spectra were all <10%, except for one subject in whom the LAC fit error was 15%. This spectrum was reacquired, with an equal fit error in the second acquisition, and the GABA values obtained from the two spectra were averaged. All line widths for non-GABA metabolites were <12 Hz. Table 1 shows all metabolite concentrations for tinnitus and control groups. It can be seen from this that all metabolites were less abundant in LAC than RAC by ∼20%. The absence of any relative differences between metabolites suggests that this was an issue of decreased signal from a particular voxel location, as has been reported in phantom studies (Edden and Barker, 2007), as opposed to chemical shift misregistration; in this phenomenon, the spatial distance between the intended and sampled voxel locations varies for the different metabolites, thus producing varying degrees of signal loss (as opposed to the consistent 20% reduction we observed).

View this table:
  • View inline
  • View popup
Table 1.

Metabolite concentrations for tinnitus and control groups

GABA spectroscopy results

Compared with controls, the tinnitus group showed GABA decreases in the LAC (median, 0.99 vs 1.08 mm/L) and RAC (median 1.12 vs 1.28 mm/L). Friedman's test showed a significant main effect of subject group (p = 0.015), and Wilcoxon's rank-sum tests found the difference to be significant in the RAC (p = 0.018) but not LAC (p = 0.30). The reduction in RAC GABA concentration in the tinnitus group remained significant (p = 0.0308) after excluding a control outlier from the analysis. These results are shown in Table 1 and Figure 2. There was no significant difference in RAC GABA concentration between the left and right ear tinnitus patients (p = 0.85). GABA concentrations showed no significant correlation with age, sex, hearing loss, hyperacusis, or any of the tinnitus severity measures.

Figure 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2.

Auditory cortex GABA concentrations in the tinnitus and control groups. AC, Auditory cortex. Boxes indicate interquartile range, with horizontal line at the median, and whiskers indicate full range, barring outliers that are indicated with + signs. GABA was significantly reduced (p < 0.05) as a main effect of subject group (tinnitus vs control) and in the RAC. Results displayed here are also tabulated in Table 1.

Subject characteristics

Fourteen tinnitus patients and an equal number of matched controls were studied. No significant differences were present between groups in terms of age, hearing loss in either ear, or hyperacusis. There was one extra female subject in the control group compared with the tinnitus group. Mean tinnitus duration was 9.4 years (range, 2–29 years). Eight of the tinnitus patients had left-ear-predominant tinnitus compared with 6 right ear. Table 2 summarizes the group characteristics and Figure 3A the group hearing thresholds.

View this table:
  • View inline
  • View popup
Table 2.

Subject characteristics of tinnitus and control groups

Figure 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 3.

Hearing and tinnitus-related subject characteristics. A, Mean pure tone hearing thresholds of the tinnitus and control groups. Error bars represent SEM. B, Positive nonparametric correlations between hearing and tinnitus measures within the tinnitus group. Significant (p < 0.05 uncorrected) correlations are denoted by asterisks. No negative correlations close to significance were observed, hence only positive correlations are shown. MHL, Mean hearing loss (in decibels; across all frequencies shown in A). Dur, Tinnitus duration (years); OvLoud, overall VAS loudness; CurLoud, current VAS loudness; OvDist, overall VAS tinnitus distress; CurDist, current VAS tinnitus distress.

There were significant positive correlations between certain tinnitus measures, as illustrated in Figure 3B. Most notably, THI score correlated with hearing loss and hyperacusis, and VAS overall tinnitus distress score correlated positively with HQ, THI, and VAS overall tinnitus loudness scores. Based on these correlations and our relative interest in certain measures above others, we eliminated hyperacusis and overall VAS distress from additional analysis.

Structural brain changes

There were no (uncorrected) significant differences in GM, WM, or CSF concentrations in the LAC or RAC between the tinnitus and control groups. However, in the subject group as a whole, GM fraction correlated negatively with both age (LAC, ρ = −0.57, p = 0.0016; RAC, ρ = −0.48, p = 0.009) and hearing loss (LAC, ρ = −0.59, p = 0.001; RAC, ρ = −0.49, p = 0.0078), and CSF fraction correlated positively with age (LAC, ρ = 0.52, p = 0.0047; RAC, ρ = 0.56, p = 0.0019) and hearing loss (LAC, ρ = 0.25, p = 0.20; RAC, ρ = 0.40, p = 0.033).

Choline spectroscopy

Choline concentration was not significantly different between the tinnitus and control groups (see Table 1). RAC choline correlated with overall VAS tinnitus loudness (ρ = 0.050, p = 0.069 uncorrected), THI score (ρ = 0.73, p = 0.034 corrected), hearing loss in the subject group as a whole (ρ = 0.62, p = 0.0055 corrected), hearing loss in the tinnitus group (ρ = 0.81, p = 0.0078 corrected), and hearing loss in the control group (ρ = 0.41, p = 0.14 uncorrected). These correlations are illustrated in Figure 4. Because choline is present in higher concentrations in WM than GM (Rae, 2014) and tissue composition correlated with age and hearing loss, we repeated significant correlation analyses after partialing out age, hearing loss, and all tissue fractions from both RAC choline concentration and the subject variable of interest. It should be kept in mind that such extensive partialization removes a lot of variance from the data, so the same strength of correlation cannot be expected. Nonetheless, these partial analyses showed that the correlation between hearing loss and choline in the whole subject group remained significant (ρ = 0.39, p = 0.040 uncorrected), and the majority of the correlation between choline and THI score remained (ρ = 0.41, p = 0.15 uncorrected).

Figure 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 4.

Correlations between choline concentration and subject variables. A, Relationship between mean hearing loss and RAC choline concentration in control (gray) and tinnitus (black) groups. Individual dots denote individual subjects, and lines represent least squares best linear fits. B, Spearman's rank correlation coefficients (ρ) between choline and subjective tinnitus variables in bilateral auditory cortices. OvLoud, VAS overall tinnitus loudness; CurLoud, VAS current tinnitus loudness; CurDist, VAS current tinnitus distress. **p < 0.01 uncorrected.

NAA and creatine spectroscopy

There were no group-level differences between tinnitus and control groups for NAA or creatine, in either auditory cortex, even before Bonferroni's correction. Choline and NAA both reflect neuronal density (Miller et al., 1996); therefore, we tested whether there were similar correlations with hearing loss and THI scores with NAA, as there were for choline, which might indicate a structural basis to observed changes. NAA did not correlate significantly with either mean hearing loss (p = 0.95 uncorrected) or THI score (p = 0.76 uncorrected).

Discussion

We studied a group of tinnitus patients and controls matched for age, sex, hearing loss, and hyperacusis; thus, observed differences can reasonably be inferred to relate to tinnitus as opposed to any of these confounding factors. Because we did not perform macromolecule suppression, for reasons of preserving the signal-to-noise ratio and allowing greater robustness to subject motion, all GABA results should be considered as indicating GABA+ (i.e., GABA plus macromolecules). This means that, as with a large proportion of human MRS studies of GABA, there is a theoretical possibility that a proportion of the findings might relate to molecules other than GABA. MRS measurements were made from a large voxel spanning almost all of auditory cortex, encompassing primary and association areas, and including some areas of surrounding non-auditory cortex. Although the primary reason for using such a large sampling area was to provide a robust GABA measurement, it is likely to have been appropriate in tinnitus, in which ongoing abnormal neurophysiological signals have been found to occur across a correspondingly large anatomical area as opposed to just circumscribed parts of the auditory cortex (Sedley et al., 2015). However, the exact size and position of the voxel used could influence the sensitivity of our measurements to detecting changes in other factors that might correlate with neurotransmitter concentrations in more localized parts of the auditory cortex. Such a voxel size and placement issue might explain why we did not observe a relationship between GABA concentration and hearing loss, as was reported recently in association with age-related hearing loss (Gao et al., 2015). Specifically, voxels in the present study were placed to capture as much of auditory cortex as possible and as little of non-auditory areas, which meant that the primary auditory cortex was at the superior edge of the voxel and slightly anterior of center. Conversely, Gao et al. centered voxels on Heschl's gyrus and therefore on or near the primary auditory cortex. Thus, it is possible that their results were relatively more strongly influenced by the primary auditory cortex than those in the present study. However, our study had other methodological differences to this one, including studying undifferentiated hearing loss as opposed to specifically the age-related type, and it is not known whether hearing loss of different etiologies also differs in its neurochemical correlates. For all significant results, there were qualitatively similar findings in the LAC as in the RAC, but the findings were much stronger and only significant in the RAC. The 20% loss of signal observed in the LAC can be potentially explained by spatial effects influencing GABA MRS measurements (Edden and Barker, 2007). Thus, it is possible that in reality the observed neurochemical correlates of tinnitus are bilateral. However, we stress the importance of obtaining direct evidence rather than assuming this to be the case. Although there was a slight excess of left-ear-predominant tinnitus subjects (8 vs 6), there were no significant differences between left and right ear tinnitus even after markedly relaxing statistical thresholds, making tinnitus laterality a very unlikely explanation.

GABA in tinnitus

We have demonstrated, for the first time, an auditory cortex GABA deficit in human tinnitus subjects. Given the tight matching of the control group for age and hearing loss, this deficit can be specifically attributed to tinnitus itself. Presently, the implications of this finding for understanding tinnitus pathophysiology as a whole are uncertain, although in light of findings in animal tinnitus models (Middleton et al., 2011; Llano et al., 2012), it is likely that this GABA deficiency is responsible for excessive magnitude and lateral spread of cortical responses to thalamic stimulation. Therefore, GABA deficiency may underlie excessive sound-evoked (Gu et al., 2010) and spontaneous (Adjamian et al., 2012) activity that has been observed previously in tinnitus in humans, even after matching for hearing loss and hyperacusis. However, GABA systems may have a more complex role in tinnitus; a recent study found evidence of increased GABA-mediated tonic inhibition in the auditory thalami of rats with noise-induced tinnitus (Sametsky et al., 2015). This excess inhibition was in turn linked to abnormal burst firing of thalamic neurons, which has been argued to trigger abnormal cortical activity linked to tinnitus (Llinás et al., 1999). Thus, the net effect of GABA on tinnitus-linked cortical activity may vary according to such factors as anatomical location and receptor type. With regard to the present results, it is possible that GABA deficiency is a primary cause of tinnitus that, in conjunction with hearing loss, removes the necessary inhibition to prevent spontaneous activity in the auditory system from being perceived as tinnitus. In addition to a role in enhancing cortical responses to sounds or spontaneous subcortical activity, GABA deficiency in the auditory cortex might also act in other ways. Various brain structures outside the auditory system, including limbic, parietal, and prefrontal regions, have been implicated in tinnitus (Lockwood et al., 1998; Moazami-Goudarzi et al., 2010; Vanneste et al., 2010; De Ridder et al., 2013); together, these may mediate the entry of the tinnitus percept into conscious perception and mediate its cognitive and affective consequences. The nonprimary auditory cortex shows rich connectivity with many of these regions in association with tinnitus (De Ridder et al., 2013; Sedley et al., 2015), and, although there is not yet direct evidence on the subject, it seems possible that GABA changes in the nonprimary auditory cortex might affect entry of the tinnitus signal into wider cortical networks. Because the present data cannot separate GABA changes in the primary from the nonprimary auditory cortex, this possibility should be considered. It is also plausible that GABA deficiency is the direct consequence of chronic stimulation (by tinnitus or its precursors originating subcortically) of the auditory cortex, but we are not aware of any evidence about the effect of chronic sensory stimulation on cortical GABA concentration that could address this possibility. It is also uncertain whether the GABA deficit is a cause or consequence of tinnitus. Although there was not a relationship between tinnitus duration and GABA concentration, which would have favored the GABA deficit being a consequence of tinnitus, this question remains open. Regardless of the exact origin and role of cortical GABA in tinnitus, it seems probable that it is a significant positive force in its pathogenesis, because reduced GABA concentration most likely indicates reduced GABAergic inhibition and therefore a relative excess of excitation in the auditory system. There remains the need for additional understanding of other aspects of GABA systems in tinnitus, such as receptor density, which presently only has limited evidence in humans (Shulman et al., 2000). As well as replicating the present findings, future studies of GABA systems in humans might involve combining GABA measurements using MRS with GABA receptor density measurements using positron emission tomography. In animals, a number of additional measures, such as glutamic acid decarboxylase expression and GABAA receptor subunit composition, might also be measured simultaneously. Studies might also examine both acute and chronic tinnitus to establish the temporal order of tinnitus phenomenology and GABA changes and also the effect of chronic physiological auditory stimulation on GABA systems.

Choline in tinnitus

Our results indicate that auditory cortex choline concentration correlates positively with both tinnitus severity (in terms of distress and possibly loudness) and hearing loss (particularly in the tinnitus group). Choline is strongly influenced by neuronal density (Miller et al., 1996), and GM loss (hence increased WM/GM ratio) increased with hearing loss, as reported previously (Husain et al., 2011). However, given the persistence of observed findings after statistically adjusting for the influence of GM and WH tissue fractions, it seems probable that choline relates directly to hearing loss and tinnitus. Because choline measured by MRS reflects increased neuronal membrane turnover (Rae, 2014), which may relate to plasticity (Gutiérrez-Fernández et al., 2012), and (although acetylcholine barely contributes to the choline signal) correlates strongly with local concentration of acetylcholine (Wang et al., 2008), we cannot presently determine which of these factors is perturbed as a function of hearing loss and tinnitus severity. Additional work to directly measure neuronal plasticity and acetylcholine is required to understand the relationship between choline and tinnitus.

In summary, we have specifically related the presence and severity of tinnitus, after eliminating confounding factors, to non-invasively measured metabolite concentrations in the auditory cortex. The finding of a GABA deficit in tinnitus patients is beyond a homeostatic response to hearing loss, underscores the importance of GABA systems in the pathophysiology of tinnitus, and may help to direct future treatments.

Footnotes

  • ↵*W.S. and J.P. are joint lead authors, and A.B. and T.D.G. are joint senior authors.

  • This study, along with the salary of W.S., was funded by United Kingdom Medical Research Council Grant MR/J011207/1, and applied tools developed under Grants NIH R01 EB016089 and P41 EB015909 from the National Institutes of Health, which also provide salary support for R.A.E.E. T.D.G. is funded by Wellcome Trust Grant WT091681MA. We acknowledge and thank the following individuals and groups for their contributions to this work: Louise Ward, Tim Hodgson, and Dorothy Wallace, the radiographers at the Newcastle Magnetic Resonance Centre, for performing the MRI scans and the Audiology Department in the Newcastle Upon Tyne Hospitals NHS Foundation Trust for assistance with patient recruitment.

  • The authors declare no competing financial interests.

  • This is an Open Access article distributed under the terms of the Creative Commons Attribution License Creative Commons Attribution 4.0 International, which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.

  • Correspondence should be addressed to William Sedley, Auditory Group, Institute of Neuroscience, Henry Wellcome Building, Medical School, Newcastle University, Framlington Place, Newcastle Upon Tyne, NE2 4HH, UK. william.sedley{at}newcastle.ac.uk

This article is freely available online through the J Neurosci Author Open Choice option.

References

  1. ↵
    1. Adjamian P,
    2. Sereda M,
    3. Zobay O,
    4. Hall DA,
    5. Palmer AR
    (2012) Neuromagnetic indicators of tinnitus and tinnitus masking in patients with and without hearing loss. J Assoc Res Otolaryngol 13:715–731, doi:10.1007/s10162-012-0340-5, pmid:22791191.
    OpenUrlCrossRefPubMed
  2. ↵
    1. Bauer CA,
    2. Brozoski TJ,
    3. Holder TM,
    4. Caspary DM
    (2000) Effects of chronic salicylate on GABAergic activity in rat inferior colliculus. Hear Res 147:175–182, doi:10.1016/S0378-5955(00)00130-1, pmid:10962183.
    OpenUrlCrossRefPubMed
  3. ↵
    1. Brozoski TJ,
    2. Spires TJ,
    3. Bauer CA
    (2007) Vigabatrin, a GABA transaminase inhibitor, reversibly eliminates tinnitus in an animal model. J Assoc Res Otolaryngol 8:105–118, doi:10.1007/s10162-006-0067-2, pmid:17221143.
    OpenUrlCrossRefPubMed
  4. ↵
    1. Brozoski T,
    2. Odintsov B,
    3. Bauer C
    (2012) Gamma-aminobutyric acid and glutamic acid levels in the auditory pathway of rats with chronic tinnitus: a direct determination using high resolution point-resolved proton magnetic resonance spectroscopy (H-MRS). Front Syst Neurosci 6:9, doi:10.3389/fnsys.2012.00009, pmid:22383901.
    OpenUrlCrossRefPubMed
  5. ↵
    1. Busto U,
    2. Sellers EM,
    3. Naranjo CA,
    4. Cappell H,
    5. Sanchez-Craig M,
    6. Sykora K
    (1986) Withdrawal reaction after long-term therapeutic use of benzodiazepines. N Engl J Med 315:854–859, doi:10.1056/NEJM198610023151403, pmid:3092053.
    OpenUrlCrossRefPubMed
  6. ↵
    1. Busto U,
    2. Fornazzari L,
    3. Naranjo CA
    (1988) Protracted tinnitus after discontinuation of long-term therapeutic use of benzodiazepines. J Clin Psychopharmacol 8:359–362, pmid:2903182.
    OpenUrlCrossRefPubMed
  7. ↵
    1. Cacace AT,
    2. Silver SM
    (2007) Applications of magnetic resonance spectroscopy to tinnitus research: initial data, current issues, and future perspectives. Prog Brain Res 166:71–81, doi:10.1016/S0079-6123(07)66007-5, pmid:17956773.
    OpenUrlCrossRefPubMed
    1. De Ridder D,
    2. Vanneste S,
    3. Weisz N,
    4. Londero A,
    5. Schlee W,
    6. Elgoyhen AB,
    7. Langguth B
    (2014) An integrative model of auditory phantom perception: Tinnitus as a unified percept of interacting separable subnetworks. Neurosci Biobehav Rev 44:16–32, doi:10.1016/j.neubiorev.2013.03.021, pmid:23597755.
    OpenUrlCrossRefPubMed
  8. ↵
    1. De Ridder D,
    2. Vanneste S,
    3. Langguth B,
    4. Llinas R
    (2015) Thalamocortical dysrhythmia: a theoretical update in tinnitus. Front Neurol 6:124, doi:10.3389/fneur.2015.00124, pmid:26106362.
    OpenUrlCrossRefPubMed
  9. ↵
    1. Edden RA,
    2. Barker PB
    (2007) Spatial effects in the detection of gamma-aminobutyric acid: improved sensitivity at high fields using inner volume saturation. Magn Reson Med 58:1276–1282, doi:10.1002/mrm.21383, pmid:17969062.
    OpenUrlCrossRefPubMed
  10. ↵
    1. Edden RA,
    2. Puts NA,
    3. Barker PB
    (2012) Macromolecule-suppressed GABA-edited magnetic resonance spectroscopy at 3T. Magn Reson Med 68:657–661, doi:10.1002/mrm.24391, pmid:22777748.
    OpenUrlCrossRefPubMed
  11. ↵
    1. Edden RA,
    2. Puts NA,
    3. Harris AD,
    4. Barker PB,
    5. Evans CJ
    (2014) Gannet: A batch-processing tool for the quantitative analysis of gamma-aminobutyric acid-edited MR spectroscopy spectra. J Magn Reson Imaging 40:1445–1452, doi:10.1002/jmri.24478, pmid:25548816.
    OpenUrlCrossRefPubMed
  12. ↵
    1. Eggermont JJ
    (2013) Hearing loss, hyperacusis, or tinnitus: what is modeled in animal research? Hear Res 295:140–149, doi:10.1016/j.heares.2012.01.005, pmid:22330978.
    OpenUrlCrossRefPubMed
  13. ↵
    1. Ethofer T,
    2. Mader I,
    3. Seeger U,
    4. Helms G,
    5. Erb M,
    6. Grodd W,
    7. Ludolph A,
    8. Klose U
    (2003) Comparison of longitudinal metabolite relaxation times in different regions of the human brain at 1.5 and 3 Tesla. Magn Reson Med 50:1296–1301, doi:10.1002/mrm.10640, pmid:14648578.
    OpenUrlCrossRefPubMed
  14. ↵
    1. Gao F,
    2. Wang G,
    3. Ma W,
    4. Ren F,
    5. Li M,
    6. Dong Y,
    7. Liu C,
    8. Liu B,
    9. Bai X,
    10. Zhao B,
    11. Edden RA
    (2015) Decreased auditory GABA+ concentrations in presbycusis demonstrated by edited magnetic resonance spectroscopy. Neuroimage 106:311–316, doi:10.1016/j.neuroimage.2014.11.023, pmid:25463460.
    OpenUrlCrossRefPubMed
  15. ↵
    1. Gu JW,
    2. Halpin CF,
    3. Nam EC,
    4. Levine RA,
    5. Melcher JR
    (2010) Tinnitus, diminished sound-level tolerance, and elevated auditory activity in humans with clinically normal hearing sensitivity. J Neurophysiol 104:3361–3370, doi:10.1152/jn.00226.2010, pmid:20881196.
    OpenUrlAbstract/FREE Full Text
  16. ↵
    1. Gutiérrez-Fernández M,
    2. Rodríguez-Frutos B,
    3. Fuentes B,
    4. Vallejo-Cremades MT,
    5. Alvarez-Grech J,
    6. Expósito-Alcaide M,
    7. Díez-Tejedor E
    (2012) CDP-choline treatment induces brain plasticity markers expression in experimental animal stroke. Neurochem Int 60:310–317, doi:10.1016/j.neuint.2011.12.015, pmid:22226841.
    OpenUrlCrossRefPubMed
  17. ↵
    1. Han SS,
    2. Nam EC,
    3. Won JY,
    4. Lee KU,
    5. Chun W,
    6. Choi HK,
    7. Levine RA
    (2012) Clonazepam quiets tinnitus: a randomised crossover study with Ginkgo biloba. J Neurol Neurosurg Psychiatry 83:821–827, doi:10.1136/jnnp-2012-302273, pmid:22626945.
    OpenUrlAbstract/FREE Full Text
  18. ↵
    1. Harris AD,
    2. Puts NA,
    3. Edden RA
    (2015) Tissue correction for GABA-edited MRS: considerations of voxel composition, tissue segmentation and tissue relaxations. J Magn Reson Imaging doi:10.1002/jmri.24903, doi:10.1002/jmri.24903, pmid:26172043, Advance online publication. Retrieved October 8, 2015.
    OpenUrlCrossRefPubMed
  19. ↵
    1. Harris AD,
    2. Glaubitz B,
    3. Near J,
    4. John Evans C,
    5. Puts NA,
    6. Schmidt-Wilcke T,
    7. Tegenthoff M,
    8. Barker PB,
    9. Edden RA
    (2014) Impact of frequency drift on gamma-aminobutyric acid-edited MR spectroscopy. Magn Reson Med 72:941–948, doi:10.1002/mrm.25009, pmid:24407931.
    OpenUrlCrossRefPubMed
  20. ↵
    1. Husain FT,
    2. Medina RE,
    3. Davis CW,
    4. Szymko-Bennett Y,
    5. Simonyan K,
    6. Pajor NM,
    7. Horwitz B
    (2011) Neuroanatomical changes due to hearing loss and chronic tinnitus: a combined VBM and DTI study. Brain Res 1369:74–88, doi:10.1016/j.brainres.2010.10.095, pmid:21047501.
    OpenUrlCrossRefPubMed
  21. ↵
    1. Khalfa S,
    2. Dubal S,
    3. Veuillet E,
    4. Perez-Diaz F,
    5. Jouvent R,
    6. Collet L
    (2002) Psychometric normalization of a hyperacusis questionnaire. ORL J Otorhinolaryngol Relat Spec 64:436–442, doi:10.1159/000067570, pmid:12499770.
    OpenUrlCrossRefPubMed
  22. ↵
    1. Kilicarslan R,
    2. Alkan A,
    3. Aralasmak A,
    4. Aksoy F,
    5. Toprak H,
    6. Yetis H,
    7. Ozturan O
    (2014) Magnetic resonance spectroscopy features of Heschl's gyri in patients with unilateral acoustic neuroma: preliminary study. Acad Radiol 21:1501–1505, doi:10.1016/j.acra.2014.07.007, pmid:25172413.
    OpenUrlCrossRefPubMed
  23. ↵
    1. Lanting CP,
    2. De Kleine E,
    3. Bartels H,
    4. Van Dijk P
    (2008) Functional imaging of unilateral tinnitus using fMRI. Acta Otolaryngol 128:415–421, doi:10.1080/00016480701793743, pmid:18368576.
    OpenUrlCrossRefPubMed
  24. ↵
    1. Llano DA,
    2. Turner J,
    3. Caspary DM
    (2012) Diminished cortical inhibition in an aging mouse model of chronic tinnitus. J Neurosci 32:16141–16148, doi:10.1523/JNEUROSCI.2499-12.2012, pmid:23152598.
    OpenUrlAbstract/FREE Full Text
  25. ↵
    1. Llinás RR,
    2. Ribary U,
    3. Jeanmonod D,
    4. Kronberg E,
    5. Mitra PP
    (1999) Thalamocortical dysrhythmia: a neurological and neuropsychiatric syndrome characterized by magnetoencephalography. Proc Natl Acad Sci U S A 96:15222–15227, doi:10.1073/pnas.96.26.15222, pmid:10611366.
    OpenUrlAbstract/FREE Full Text
  26. ↵
    1. Lockwood AH,
    2. Salvi RJ,
    3. Coad ML,
    4. Towsley ML,
    5. Wack DS,
    6. Murphy BW
    (1998) The functional neuroanatomy of tinnitus: evidence for limbic system links and neural plasticity. Neurology 50:114–120, doi:10.1212/WNL.50.1.114, pmid:9443467.
    OpenUrlCrossRefPubMed
  27. ↵
    1. Melcher JR,
    2. Levine RA,
    3. Bergevin C,
    4. Norris B
    (2009) The auditory midbrain of people with tinnitus: abnormal sound-evoked activity revisited. Hear Res 257:63–74, doi:10.1016/j.heares.2009.08.005, pmid:19699287.
    OpenUrlCrossRefPubMed
  28. ↵
    1. Mescher M,
    2. Merkle H,
    3. Kirsch J,
    4. Garwood M,
    5. Gruetter R
    (1998) Simultaneous in vivo spectral editing and water suppression. NMR Biomed 11:266–272, doi:10.1002/(SICI)1099-1492(199810)11:6<266::AID-NBM530>3.0.CO%3B2-J, pmid:9802468.
    OpenUrlCrossRefPubMed
  29. ↵
    1. Middleton JW,
    2. Kiritani T,
    3. Pedersen C,
    4. Turner JG,
    5. Shepherd GM,
    6. Tzounopoulos T
    (2011) Mice with behavioral evidence of tinnitus exhibit dorsal cochlear nucleus hyperactivity because of decreased GABAergic inhibition. Proc Natl Acad Sci U S A 108:7601–7606, doi:10.1073/pnas.1100223108, pmid:21502491.
    OpenUrlAbstract/FREE Full Text
  30. ↵
    1. Miller BL,
    2. Chang L,
    3. Booth R,
    4. Ernst T,
    5. Cornford M,
    6. Nikas D,
    7. McBride D,
    8. Jenden DJ
    (1996) In vivo 1H MRS choline: correlation with in vitro chemistry/histology. Life Sci 58:1929–1935, doi:10.1016/0024-3205(96)00182-8, pmid:8637421.
    OpenUrlCrossRefPubMed
  31. ↵
    1. Mlynárik V,
    2. Gruber S,
    3. Moser E
    (2001) Proton T (1) and T (2) relaxation times of human brain metabolites at 3 Tesla. NMR Biomed 14:325–331, doi:10.1002/nbm.713, pmid:11477653.
    OpenUrlCrossRefPubMed
  32. ↵
    1. Moazami-Goudarzi M,
    2. Michels L,
    3. Weisz N,
    4. Jeanmonod D
    (2010) Temporo-insular enhancement of EEG low and high frequencies in patients with chronic tinnitus. QEEG study of chronic tinnitus patients. BMC Neurosci 11:40, doi:10.1186/1471-2202-11-40, pmid:20334674.
    OpenUrlCrossRefPubMed
  33. ↵
    1. Mullins PG,
    2. McGonigle DJ,
    3. O'Gorman RL,
    4. Puts NA,
    5. Vidyasagar R,
    6. Evans CJ,
    7. Edden RA
    (2014) Current practice in the use of MEGA-PRESS spectroscopy for the detection of GABA. Neuroimage 86:43–52, doi:10.1016/j.neuroimage.2012.12.004, pmid:23246994.
    OpenUrlCrossRefPubMed
  34. ↵
    1. Naressi A,
    2. Couturier C,
    3. Castang I,
    4. de Beer R,
    5. Graveron-Demilly D
    (2001) Java-based graphical user interface for MRUI, a software package for quantitation of in vivo/medical magnetic resonance spectroscopy signals. Comput Biol Med 31:269–286, doi:10.1016/S0010-4825(01)00006-3, pmid:11334636.
    OpenUrlCrossRefPubMed
  35. ↵
    1. Near J,
    2. Edden R,
    3. Evans CJ,
    4. Paquin R,
    5. Harris A,
    6. Jezzard P
    (2014) Frequency and phase drift correction of magnetic resonance spectroscopy data by spectral registration in the time domain. Magn Reson Med doi:10.1002/mrm.25094, doi:10.1002/mrm.25094, pmid:24436292, Advance online publication. Retrieved October 8, 2015.
    OpenUrlCrossRefPubMed
  36. ↵
    1. Newman CW,
    2. Jacobson GP,
    3. Spitzer JB
    (1996) Development of the tinnitus handicap inventory. Arch Otolaryngol Head Neck Surg 122:143–148, doi:10.1001/archotol.1996.01890140029007, pmid:8630207.
    OpenUrlCrossRefPubMed
  37. ↵
    1. Noreña AJ,
    2. Eggermont JJ
    (2003) Changes in spontaneous neural activity immediately after an acoustic trauma: implications for neural correlates of tinnitus. Hear Res 183:137–153, doi:10.1016/S0378-5955(03)00225-9, pmid:13679145.
    OpenUrlCrossRefPubMed
  38. ↵
    1. Noreña AJ,
    2. Farley BJ
    (2013) Tinnitus-related neural activity: theories of generation, propagation, and centralization. Hear Res 295:161–171, doi:10.1016/j.heares.2012.09.010, pmid:23088832.
    OpenUrlCrossRefPubMed
  39. ↵
    1. Puts NA,
    2. Edden RA
    (2012) In vivo magnetic resonance spectroscopy of GABA: a methodological review. Prog Nucl Magn Reson Spectrosc 60:29–41, doi:10.1016/j.pnmrs.2011.06.001, pmid:22293397.
    OpenUrlCrossRefPubMed
  40. ↵
    1. Rae CD
    (2014) A guide to the metabolic pathways and function of metabolites observed in human brain 1H magnetic resonance spectra. Neurochem Res 39:1–36, doi:10.1007/s11064-013-1199-5, pmid:24258018.
    OpenUrlCrossRefPubMed
  41. ↵
    1. Sametsky EA,
    2. Turner JG,
    3. Larsen D,
    4. Ling L,
    5. Caspary DM
    (2015) Enhanced GABAA-mediated tonic inhibition in auditory thalamus of rats with behavioral evidence of tinnitus. J Neurosci 35:9369–9380, doi:10.1523/JNEUROSCI.5054-14.2015, pmid:26109660.
    OpenUrlAbstract/FREE Full Text
  42. ↵
    1. Sedley W,
    2. Cunningham MO
    (2013) Do cortical gamma oscillations promote or suppress perception? An under-asked question with an over-assumed answer. Front Hum Neurosci 7:595, doi:10.3389/fnhum.2013.00595, pmid:24065913.
    OpenUrlCrossRefPubMed
  43. ↵
    1. Sedley W,
    2. Gander PE,
    3. Kumar S,
    4. Oya H,
    5. Kovach CK,
    6. Nourski KV,
    7. Kawasaki H,
    8. Howard MA 3rd.,
    9. Griffiths TD
    (2015) Intracranial mapping of a cortical tinnitus system using residual inhibition. Curr Biol 25:1208–1214, doi:10.1016/j.cub.2015.02.075, pmid:25913402.
    OpenUrlCrossRefPubMed
  44. ↵
    1. Seki S,
    2. Eggermont JJ
    (2003) Changes in spontaneous firing rate and neural synchrony in cat primary auditory cortex after localized tone-induced hearing loss. Hear Res 180:28–38, doi:10.1016/S0378-5955(03)00074-1, pmid:12782350.
    OpenUrlCrossRefPubMed
  45. ↵
    1. Shulman A,
    2. Strashun AM,
    3. Seibyl JP,
    4. Daftary A,
    5. Goldstein B
    (2000) Benzodiazepine receptor deficiency and tinnitus. Int Tinnitus J 6:98–111, pmid:14689626.
    OpenUrlPubMed
  46. ↵
    1. Tass PA,
    2. Adamchic I,
    3. Freund HJ,
    4. von Stackelberg T,
    5. Hauptmann C
    (2012) Counteracting tinnitus by acoustic coordinated reset neuromodulation. Restor Neurol Neurosci 30:137–159, doi:10.3233/RNN-2012-110218, pmid:22414611.
    OpenUrlCrossRefPubMed
  47. ↵
    1. Tkác I,
    2. Starcuk Z,
    3. Choi IY,
    4. Gruetter R
    (1999) In vivo 1H NMR spectroscopy of rat brain at 1 ms echo time. Magn Reson Med 41:649–656, doi:10.1002/(SICI)1522-2594(199904)41:4<649::AID-MRM2>3.0.CO%3B2-G, pmid:10332839.
    OpenUrlCrossRefPubMed
  48. ↵
    1. Vanneste S,
    2. Plazier M,
    3. der Loo Ev,
    4. de Heyning PV,
    5. Congedo M,
    6. De Ridder D
    (2010) The neural correlates of tinnitus-related distress. Neuroimage 52:470–480, doi:10.1016/j.neuroimage.2010.04.029, pmid:20417285.
    OpenUrlCrossRefPubMed
  49. ↵
    1. Wang XC,
    2. Du XX,
    3. Tian Q,
    4. Wang JZ
    (2008) Correlation between choline signal intensity and acetylcholine level in different brain regions of rat. Neurochem Res 33:814–819, doi:10.1007/s11064-007-9509-4, pmid:17940879.
    OpenUrlCrossRefPubMed
  50. ↵
    1. Weisz N,
    2. Müller S,
    3. Schlee W,
    4. Dohrmann K,
    5. Hartmann T,
    6. Elbert T
    (2007) The neural code of auditory phantom perception. J Neurosci 27:1479–1484, doi:10.1523/JNEUROSCI.3711-06.2007, pmid:17287523.
    OpenUrlAbstract/FREE Full Text
  51. ↵
    1. Zheng Y,
    2. Vagal S,
    3. McNamara E,
    4. Darlington CL,
    5. Smith PF
    (2012) A dose-response analysis of the effects of L-baclofen on chronic tinnitus caused by acoustic trauma in rats. Neuropharmacology 62:940–946, doi:10.1016/j.neuropharm.2011.09.027, pmid:22005094.
    OpenUrlCrossRefPubMed
Back to top

In this issue

The Journal of Neuroscience: 35 (44)
Journal of Neuroscience
Vol. 35, Issue 44
4 Nov 2015
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Advertising (PDF)
  • Ed Board (PDF)
Email

Thank you for sharing this Journal of Neuroscience article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Human Auditory Cortex Neurochemistry Reflects the Presence and Severity of Tinnitus
(Your Name) has forwarded a page to you from Journal of Neuroscience
(Your Name) thought you would be interested in this article in Journal of Neuroscience.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
View Full Page PDF
Citation Tools
Human Auditory Cortex Neurochemistry Reflects the Presence and Severity of Tinnitus
William Sedley, Jehill Parikh, Richard A.E. Edden, Valerie Tait, Andrew Blamire, Timothy D. Griffiths
Journal of Neuroscience 4 November 2015, 35 (44) 14822-14828; DOI: 10.1523/JNEUROSCI.2695-15.2015

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Request Permissions
Share
Human Auditory Cortex Neurochemistry Reflects the Presence and Severity of Tinnitus
William Sedley, Jehill Parikh, Richard A.E. Edden, Valerie Tait, Andrew Blamire, Timothy D. Griffiths
Journal of Neuroscience 4 November 2015, 35 (44) 14822-14828; DOI: 10.1523/JNEUROSCI.2695-15.2015
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Keywords

  • auditory cortex
  • choline
  • GABA
  • MR spectroscopy
  • tinnitus

Responses to this article

Respond to this article

Jump to comment:

No eLetters have been published for this article.

Related Articles

Cited By...

More in this TOC Section

Articles

  • Choice Behavior Guided by Learned, But Not Innate, Taste Aversion Recruits the Orbitofrontal Cortex
  • Maturation of Spontaneous Firing Properties after Hearing Onset in Rat Auditory Nerve Fibers: Spontaneous Rates, Refractoriness, and Interfiber Correlations
  • Insulin Treatment Prevents Neuroinflammation and Neuronal Injury with Restored Neurobehavioral Function in Models of HIV/AIDS Neurodegeneration
Show more Articles

Neurobiology of Disease

  • Targeting astrocyte signaling alleviates cerebrovascular and synaptic function deficits in a diet-based mouse model of small cerebral vessel disease
  • TEMPORAL IRREVERSIBILITY OF LARGE-SCALE BRAIN DYNAMICS IN ALZHEIMER'S DISEASE
  • mTORC2 Inhibition Improves Morphological Effects of PTEN Loss, But Does Not Correct Synaptic Dysfunction or Prevent Seizures
Show more Neurobiology of Disease
  • Home
  • Alerts
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Issue Archive
  • Collections

Information

  • For Authors
  • For Advertisers
  • For the Media
  • For Subscribers

About

  • About the Journal
  • Editorial Board
  • Privacy Policy
  • Contact
(JNeurosci logo)
(SfN logo)

Copyright © 2023 by the Society for Neuroscience.
JNeurosci Online ISSN: 1529-2401

The ideas and opinions expressed in JNeurosci do not necessarily reflect those of SfN or the JNeurosci Editorial Board. Publication of an advertisement or other product mention in JNeurosci should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in JNeurosci.